ProShares Ultra Nasdaq Biotechnology (BIB) Investment Research Dashboard
About ProShares Ultra Nasdaq Biotechnology (BIB) stock analysis
Get live BIB stock price $98.89, comprehensive ProShares Ultra Nasdaq Biotechnology stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time BIB stock data and investment insights.
Loading chart data...
ProShares Ultra Nasdaq Biotechnology (BIB) Overview
ProShares Ultra Nasdaq Biotechnology (BIB) is a publicly traded company in the Financial Services sector , specifically within the Asset Management industry . As of the latest trading session, BIB trades at $98.89 with a market capitalization of 83.07M . Over the past 52 weeks, BIB has traded between $49.24 and $110.25 , with the current price positioned at approximately 81% of this range . The...
Key Takeaways
- Operates in the Financial Services sector (Asset Management)
- Market cap: 83.07M
- Current price: $98.89
- 52-week range: $49.24 - $110.25
- P/E ratio: 28.01
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating...
Company Information
- CEO
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- N/A
Contact Information
- Address
- 7501 Wisconsin Avenue, Suite 1000E
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Listed on major US exchange (NASDAQ) providing liquidity and transparency
✓ Growth-oriented company with premium valuation (P/E: 28.0)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for ProShares Ultra Nasdaq Biotechnology shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for ProShares Ultra Nasdaq Biotechnology
- ⚠Investors should consider how ProShares Ultra Nasdaq Biotechnology fits within their overall portfolio allocation
Market Cap
83.07M
P/E Ratio (TTM)
28.01
Beta
1.11
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BIB with peer companies:
- Price
- $44.42-0.22% (1D)
- Market cap
- 88.19M
- Price
- $35.66+0.00% (1D)
- Market cap
- 68.70M
- Price
- $25.35-0.90% (1D)
- Market cap
- 59.99M
- Price
- $42.60-1.78% (1D)
- Market cap
- 86.38M
- Price
- $36.02-0.75% (1D)
- Market cap
- 102.70M
- Price
- $56.09-1.47% (1D)
- Market cap
- 73.72M
- Price
- $37.63-0.60% (1D)
- Market cap
- 72.39M
- Price
- $28.97-0.80% (1D)
- Market cap
- 53.08M
- Price
- $36.03-0.29% (1D)
- Market cap
- 64.70M
- Price
- $73.93-0.88% (1D)
- Market cap
- 55.91M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
Financial Services (1D)
91/100 ⭐⭐⭐⭐⭐
- Overall
- -0.0%
- NYSE
- -0.5%
- NASDAQ
- +0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Communication Services | +1.2% | +2.7% | +4.1% | 22.5 | 94/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.0% | +3.3% | +3.8% | 19.2 | 91/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.4% | +2.3% | +2.4% | 24.0 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +0.2% | +2.1% | +1.7% | 29.9 | 60/100⭐⭐⭐⭐ |
| Basic Materials | -0.4% | +0.3% | -1.0% | 25.1 | 58/100⭐⭐⭐⭐ |
| Energy | -0.0% | -3.8% | -3.1% | 19.5 | 42/100⭐⭐⭐ |
| Real Estate | -0.7% | -0.3% | -1.7% | 29.0 | 41/100⭐⭐⭐ |
| Consumer Cyclical | +0.9% | +0.1% | -5.9% | 42.7 | 31/100⭐⭐ |
| Utilities | -1.1% | -3.1% | -5.9% | 26.3 | 22/100⭐ |
| Industrials | -1.0% | +0.1% | -12.6% | 29.5 | 19/100⭐ |
| Technology | +0.4% | -2.5% | -9.8% | 41.1 | 18/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.